Fish intake, contaminants, and human health: evaluating the risks and the benefits

Summary

This JAMA evidence synthesis remains the most-cited single statement on whether fish consumption is, on balance, beneficial or harmful given the dual presence of cardioprotective omega-3 fatty acids and contaminants like methylmercury and PCBs. Mozaffarian and Rimm reviewed the strength of evidence on both sides for adults and for vulnerable groups (children, women of childbearing age) and reached an unambiguous conclusion: the benefits dominate the risks for adult populations. Their pooled estimate found that modest fish consumption — 1–2 servings per week, particularly fatty species rich in EPA and DHA — reduces coronary death risk by 36 percent and total mortality by 17 percent. They identified an EPA+DHA intake of about 250 mg/day as sufficient for primary cardiovascular prevention. For pregnant women and young children, they recommended species selection to minimize methylmercury exposure (avoiding swordfish, king mackerel, tilefish, shark) while still consuming two servings of lower-mercury fish per week. The paper's framing — benefits substantially outweigh risks — has anchored most subsequent dietary fish guidance.